• 1
    Talley NJ, O'Keefe EA, Zinsmeister AR, et al. Prevalence of gastrointestinal symptoms in the elderly: a population-based study. Gastroenterol 1992; 102: 895901.
  • 2
    Cheng C, Chan AO, Hui WM, et al. Coping strategies, illness perception, anxiety, and depression of patients with idiopathic constipation: a population-based study. Aliment Pharmacol Ther 2003; 18: 31926.
  • 3
    Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel disorder. Gastroenterol 2006; 130: 148091.
  • 4
    Buchheit KH, Buhl T. Prokinetic benzamides stimulate peristaltic activity in the isolated guinea pig ileum by activation of 5-HT4 receptors. Eur J Pharmacol 1991; 205: 2038.
  • 5
    Buchheit KH, Gamse R, Pfannkuche HJ. SDZ 205-557, a selective, surmountable antagonist for 5-HT4 receptors in the isolated guinea pig ileum. Pharmacol 1992; 345: 387393.
  • 6
    Grider JR, Foxx-Orenstein AE, Jin JG. 5 Hydroxy-tryptamine 4 receptor agonists initiate the peristaltic reflex in human, rat, and guinea pig intestine. Gastroenterol 1998; 115: 37080.
  • 7
    Grider JR, Kuemmerle JF, Jin J-G. 5-HT released by mucosal stimulation acts via 5 HT4 receptors to release the sensory transmitter CGRP and initiate the peristaltic reflex. Gastroenterol 1994; 106: A506.
  • 8
    Foxx-Orenstein AE, Kuemmerle JF, Grider JR. The peristaltic reflex induced by mucosal stimuli in human and guinea pig intestine is mediated by distinct mucosal 5-HT receptors. Gastroenterol 1995; 108: A600.
  • 9
    Nguyen A, Camilleri M, Kost LJ, et al. SDZ HTF 919 Stimulates Canine Colonic Motility and Transit In Vivo. J Pharmacol Exp Ther 1997; 280: 12706.
  • 10
    Degen L., Matzinger D., Merz M., Appel-Dingemanse S., Maecke H., Beglinger C. Tegaserod (HTF 919), a 5-HT4 receptor partial agonist accelerates gastrointestinal (GI) transit. Gastroenterol 2000; 118(Suppl. 2): A845; 4436.
  • 11
    Prather C., Camilleri M., Zinsmeister A., McKinzie S., Thomforde G. Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome. Gastroenterol 2000; 118: 4638.
  • 12
    Johanson JF, Wald A, Tougas G, et al. Effect of tegaserod in chronic constipation: a randomized, double-blind, controlled trial. Clin Gastroenterol Hepatol 2004; 2: 796805.
  • 13
    Kamm MA, Muller-Lissner S, Talley NJ, et al. Tegaserod for the treatment of chronic constipation: a randomized, double-blind, placebo-controlled multinational study. Am J Gastroenterol 2005; 100: 36272.
    Direct Link:
  • 14
    Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol 1997; 32: 9204.
  • 15
    Ware Jr JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 47383.
  • 16
    Chaussade S, Khyari A, Roche H, et al. Determination of total and segmental colonic transit time in constipated patients. Results in 91 patients with a new simplified method. Dig Dis Sci 1989; 34: 116872.
  • 17
    Metcalf AM, Phillips SF, Zinsmeister AR, MacCarty RL, Beart RW, Wolff BG. Simplified assessment of segmental colonic transit. Gastroenterol 1987; 92: 4047.
  • 18
    Kellow J, Lee OY, Chang FY, et al. An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome. Gut 2003; 52: 6716.
  • 19
    Müller-Lissner SA, Fumagalli I, Bardhan K, et al. Tegaserod, a 5-HT4 receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation. Aliment Pharmacol Ther 2001; 15: 165566.
  • 20
    Novick J, Miner P, Kranse R, et al. A randomized, double-blind, placebo-controlled trial of tegaserod in female patients suffering from irritable bowel syndrome with constipation. Aliment Pharmacol Ther 2002; 16: 187788.
  • 21
    Rao SS, Ozturk R, Laine L. Clinical utility of diagnostic tests for constipation in adults: a systematic review. Am J Gastroenterol. 2005; 100: 160515.
    Direct Link:
  • 22
    Ding JH, Fu CG, Zhao RH, Meng RG. Serotonin transporter gene polymorphism in slow transit constipation. Zhonghua Wei Chang Wai Ke Za Zhi. 2006; 9: 32830.